Skip to main content
. 2011 Sep;85(17):9039–9050. doi: 10.1128/JVI.02675-10

Fig. 5.

Fig. 5.

Effects of the 386 glycosylation site on the HIV-1 inhibition curves of GRFT and b12. (A and B) HIV-1 QH0692.42 (A) and COT6-V295N/S448N (B) were neutralized in TZM-bl cells with GRFT and b12, in combination and alone. The shift in the inhibition curves of the two compounds combined relative to each compound alone are shown. (C and D) The same experiment as in panels A and B but using QH0692-N386Q and COT6-V295N/S448N/N386Q, respectively. The dashed lines indicate 50 and 80% inhibition. The graphs are representative of three different experiments.